MedPath

Analysis of Surgery results in repeat slippage of disc occuring again after 1st surgery.

Completed
Conditions
Recurrent Disc Prolapse
Registration Number
CTRI/2017/10/010221
Lead Sponsor
Stavya Spine Hospital and Research Institute
Brief Summary

This study is a retrospective analysis of 100 patients who have undergone surgery for recurrence of Lumbar Disc Prolapse. 

Patients who met all inclusion/exclusion criteria will be enrolled in the study.

Patients will be evaluated for clinical outcome by recording  Oswestry Disability Index (ODI) Score and Visual Analogue Scores (VAS) and

radiological  outcome using X-Rays of L.S.Spine at the final follow up , after primary surgery by lumbar fusion at our center.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 1.Age : 25 – 85 yrs , Male or Female 2.Single level Lumbosacral fusion L4-5 or L5-S1 operated by conventional posterior approach for recurrent disc.
  • 3.Psychosocially, mentally and physically able to fully comply with this protocol including adhering to completing forms and other study procedures.
  • 4.Personally signed and dated informed consent document prior to any study-related procedures indicating that the patient has been informed of all pertinent aspects of the study.
Exclusion Criteria
  • 1.Redo discectomy 2.Lumbar infection.
  • 3.Lumbar laminectomy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1 ODI and VAS Scores12 - 18 months
2 X-Rays of L S Spine AP and12 - 18 months
Lateral12 - 18 months
Secondary Outcome Measures
NameTimeMethod
1 ODI and VAS Scores2 X-Rays of L S Spine AP and

Trial Locations

Locations (1)

Stavya Spine Hospital and Research Institute

🇮🇳

Ahmadabad, GUJARAT, India

Stavya Spine Hospital and Research Institute
🇮🇳Ahmadabad, GUJARAT, India
Dr D Devanand
Principal investigator
07874444091
drdanand@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.